Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Star Sports Medicine CoHKSE:01609 -0.21%20 Net Margin % is 36.38% as of Dec. 2025, which is 28% above its 10-year median of 28.34. GuruFocus rates HKSE:01609 with a GF Score™ of 20/100. The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Star Sports Medicine Co ranks better than 97.18% on this metric.
The historical rank and industry rank for Star Sports Medicine Co's Net Margin % or its related term are showing as below:
HKSE:01609'
s Net Margin % Range Over the Past 10 Years
Min: 23.94 Med: 28.34 Max: 36.38
Current: 36.38
HKSE:01609's Net Margin % is ranked better than 97.18% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 2.2
vs HKSE:01609: 36.38
Star Sports Medicine Co (HKSE:01609) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Star Sports Medicine Co Net Margin % Related Terms
Star Sports Medicine Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01609 vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, Star Sports Medicine Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Sports Medicine Co Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Star Sports Medicine Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Star Sports Medicine Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Star Sports Medicine Co (HKSE:01609) has a Net Margin % of 36.38% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Star Sports Medicine Co and its competitors. This is 28% above median its historical median of 28.34. Over the past decade, Star Sports Medicine Co's Net Margin % has ranged from 23.94 to 36.38. According to the industry distribution chart, Star Sports Medicine Co ranks #23 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 2.8%.
Is Star Sports Medicine Co's Net Margin % too high?
Star Sports Medicine Co's current Net Margin % of 36.38% is 28% above median its 10-year median of 28.34. Over the past 10 years, this metric has ranged from a low of 23.94 to a high of 36.38. The Medical Devices & Instruments industry median Net Margin % is 2.20. Star Sports Medicine Co's value of 36.38% is 1553.6% above this industry median. Based on the distribution chart, Star Sports Medicine Co ranks #23 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Star Sports Medicine Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Star Sports Medicine Co's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Star Sports Medicine Co ranks #23 out of 815 companies for Net Margin %. This places Star Sports Medicine Co in the top 3% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.20. Star Sports Medicine Co's value of 36.38% is 1553.6% above this benchmark. Historically, Star Sports Medicine Co's own Net Margin % has ranged from 23.94 to 36.38 over the past decade. While the company's 10-year median is 28.34 vs. the industry median of 2.20, Star Sports Medicine Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.20, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Star Sports Medicine Co's current Net Margin % of 36.38% is 1553.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Star Sports Medicine Co and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Star Sports Medicine Co's current Net Margin % is 36.38%, which is 28% above median its own 10-year median of 28.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Sports Medicine Co stock overvalued right now?
Star Sports Medicine Co (HKSE:01609) has a current Net Margin % of 36.38%. The current Net Margin % is 36.38%, which is 28% above median its 10-year median of 28.34 and 1553.6% above the Medical Devices & Instruments industry median of 2.20. Star Sports Medicine Co's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Star Sports Medicine Co (HKSE:01609), the current Net Margin % is 36.38% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Star Sports Medicine Co Ltd is a China-based medical device company specializing in clinical sports medicine solutions. It is principally engaged in the research and development and sales of medical devices and equipment in the field of sports medicine. The product line covers medical implants, surgical equipment and associated medical consumables. The company has only one reportable operating segment, which is the sale of sports medicine products. It derives revenue from the sales of (i) medical implants and (ii) surgical equipment and associated medical consumables, with the majority of revenue generated from the sales of Medical implants. Geographically, the maximum revenue is derived from the Chinese mainland.
20GF Score
Get the complete analysis for HKSE:01609
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01609 has been successfully added to your 
